Latest News

Press Releases

May 18, 2021

Frontier Medicines to Present at Two Upcoming Investor Conferences
more

March 31, 2021

Frontier Medicines Appoints Seasoned Executive Gregory Chow as Chief Financial Officer
more

March 30, 2021

Frontier Medicines Appoints Drug Development Expert David M. Goldstein, Ph.D., to its Board of Directors
more

January 8, 2021

Frontier Medicines to Present at the 39th Annual J.P. Morgan Healthcare Conference
more

December 2, 2020

Frontier Medicines and AbbVie Establish Global Partnership to Discover and Develop Novel Therapies and E3 Degraders Against Difficult-to-Drug Targets
more

November 11, 2019

Chemical & Engineering News Names Frontier Medicines One of Its 10 Chemistry Start-Ups to Watch
more

September 23, 2019

FierceBiotech Names Frontier Medicines One of Its “Fierce 15” Biotech Companies of 2019
more

July 31, 2019

Frontier Medicines Announces Three Executive Hires: Chief Scientific Officer, Chief Technology Officer & Head of Degrader Technologies
more

June 25, 2019

Frontier Medicines Launches with $67 Million to Develop Novel Medicines that Drug the “Undruggable” Targets Driving Human Disease
more

Presentations

UPCOMING EVENTS

No upcoming events.

PAST EVENTS

Jefferies Virtual Healthcare Conference
June 4, 2021 - 12:00 pm EDT
Webcast

RBC Capital Markets Global Healthcare Conference
May 20, 2021 - 12:40 pm EDT
Webcast

Select Media Coverage

2020

December 3, 2020

BioSpace: Frontier and AbbVie Team Up Against Elusive Protein Targets
Read article

December 3, 2020

Fierce Biotech: AbbVie Pays Frontier $55M to Pursue Hard-to-Drug Targets
Read article

December 2, 2020

BioWorld: In Rugged E3 Space, AbbVie Delivers Frontier Justice – the Good Kind – via $1B-Plus Deal
Read article

December 2, 2020

Endpoints News: AbbVie Eyes Cancer, Immunology in Latest Protein Degradation Pact, Handing Frontier Medicines $55M Upfront
Read article

2019

November 11, 2019

C&EN: C&EN Names Frontier 2019 10 Start-Ups to Watch
Read article

September 23, 2019

FierceBiotech: FierceBiotech Names Frontier Medicines One of Its “Fierce 15” Biotech Companies of 2019
Read article

June 26, 2019

BioCentury: Frontier Aims for Previously Unreachable 'Hot Spot' Targets with $67M Series A
Read article

June 26, 2019

BioWorld: Frontier Medicines Launches with a $67M Series A Round
Read article

June 26, 2019

WSJ Venture Capital: Biotech Entrepreneur Chris Varma Scores $67 Million for Frontier Medicines
Read article

Media Center

MEDIA CONTACT

Alexandra Santos
pr@frontiermeds.com

LOGOS

Right click and choose “Save Link As” to download a high resolution image.